According to the WHO, the number of people living with diabetes increased from 200 million in 1990 to 830 million in 2022. In 2021, diabetes and kidney disease due to diabetes caused over 2 million deaths. Furthermore, around 11% of cardiovascular deaths were attributed to high blood glucose levels.

The role of pharmacists in preventing and managing diabetes cannot be overstated. Pharmacists are equipped with the necessary skills and knowledge to participate in diabetes care in several ways, ranging from diabetes prevention to screenings and referrals to disease state management and treatment optimisation.

In the context of diabetes, pharmacists can leverage their expertise and use new technologies to provide patient care as a valuable member of the healthcare team, thereby making a unique contribution to the clinical outcomes of medicines therapy and consequently to patients’ quality of life.

FIP is supporting its member organisations to transform pharmacy practice and promote improved service delivery through the ONE FIP Practice Transformation Programme on Diabetes. The programme aims to provide strategic support to FIP member organisations and individual members to develop and implement pharmacy services that can have a sustained impact in the screening, prevention, management, and treatment optimisation of diabetes.

You can find information about the programme in the submenus.